4-[(3-BroMophenyl)Methoxy]oxane
![4-[(3-BroMophenyl)Methoxy]oxane price.](/CAS/20150408/GIF/1247385-45-0.gif)
|
- $45 - $677
- Product name: 4-[(3-BroMophenyl)Methoxy]oxane
- CAS: 1247385-45-0
- MF: C12H15BrO2
- MW: 271.15
- EINECS:
- MDL Number:
- Synonyms:4-[(3-BroMophenyl)Methoxy]oxane;2H-Pyran, 4-[(3-bromophenyl)methoxy]tetrahydro-
5 prices
Selected condition：
Brand
- AK Scientific
- Chemenu
- Crysdot
- TRC
Package
- 25mg
- 250mg
- 5g
- ManufacturerAK Scientific
- Product numberZ8829
- Product description4-[(3-Bromophenyl)methoxy]oxane
- Packaging250mg
- Price$184
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM317816
- Product description4-[(3-Bromophenyl)methoxy]oxane 95%
- Packaging5g
- Price$640
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11316666
- Product description4-[(3-Bromophenyl)methoxy]oxane 95+%
- Packaging5g
- Price$677
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB698333
- Product description4-[(3-Bromophenyl)methoxy]oxane
- Packaging25mg
- Price$45
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB698333
- Product description4-[(3-Bromophenyl)methoxy]oxane
- Packaging250mg
- Price$75
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | Z8829 | 4-[(3-Bromophenyl)methoxy]oxane | 250mg | $184 | 2021-12-16 | Buy |
| Chemenu | CM317816 | 4-[(3-Bromophenyl)methoxy]oxane 95% | 5g | $640 | 2021-12-16 | Buy |
| Crysdot | CD11316666 | 4-[(3-Bromophenyl)methoxy]oxane 95+% | 5g | $677 | 2021-12-16 | Buy |
| TRC | B698333 | 4-[(3-Bromophenyl)methoxy]oxane | 25mg | $45 | 2021-12-16 | Buy |
| TRC | B698333 | 4-[(3-Bromophenyl)methoxy]oxane | 250mg | $75 | 2021-12-16 | Buy |
Properties
Boiling point :340.8±37.0 °C(Predicted)
Density :1.38±0.1 g/cm3(Predicted)
Density :1.38±0.1 g/cm3(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|